ViennaLab introduces ss-globulin mutation assay:
This article was originally published in Clinica
A new screening test for nine of the most common Mediterranean ss-globulin mutations has been introduced by ViennaLab (Austria). The test covers over 90% of Mediterranean ss-globin anomalies. The reverse hybridisation-based test takes a day to perform and a single test strip can discriminate between heterozygous-, compound heterozygous- and homozygous-affected individuals. The assay is designed for carrier screening using blood samples, but the company expects it to be able to carry out prenatal diagnosis by chorionic villus sampling if DNA extraction methods suitable for small tissue samples are applied.